Tea catechins are green-tea plant compounds, used in drinks or capsules for longevity, cholesterol, blood pressure, and weight. Trials support a small cholesterol improvement, a very small blood-pressure drop, small weight loss, and smaller blood-sugar shifts, not in every group. Lower death rates track the drink, not capsules; the drink has the longer safety record. Liver-enzyme rises are tied to capsules; no basis for treating capsules as a longevity drug. (Full Review)
| Marker | Target | Why |
|---|---|---|
| ALT | <25 U/L | Catches extract-related liver stress early |
| AST | <25 U/L | Pairs with ALT when a liver signal is suspected |
| LDL cholesterol | <100 mg/dL; <70 mg/dL if cardiovascular risk is already high | The lipid outcome catechin trials actually move |
| Ferritin | 50–150 ng/mL | Shows whether meal-time tea is draining iron stores |
| Fasting glucose | 75–90 mg/dL | Tracks the small glycemic signal |
| Blood pressure | <120/80 mmHg | Tracks the roughly 1 mmHg average shift |
Cadence: Extract: baseline liver panel, lipids, ferritin, fasting glucose, and seated blood pressure before the start; ALT at about 4 weeks, about 12 weeks, then every 6–12 months if the extract continues. Lipids and glucose at 12 weeks if they are the reason for use. An ALT rise is a described reason for stopping and rechecking, not for pushing the dose. Brewed tea only: how the person feels, plus a routine annual panel, not a catechin-specific schedule.